In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz

Antivir Ther. 2001 Jun;6(2):143-4.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Alkynes
  • Anti-HIV Agents / pharmacology*
  • Anti-HIV Agents / therapeutic use
  • Benzoxazines
  • Cyclopropanes
  • Drug Resistance, Microbial / genetics
  • Drug Synergism
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects*
  • HIV-1 / genetics
  • HIV-1 / isolation & purification
  • HIV-1 / metabolism
  • Humans
  • In Vitro Techniques
  • Inhibitory Concentration 50
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / virology
  • Nevirapine / pharmacology*
  • Oxazines / pharmacology*
  • Reverse Transcriptase Inhibitors / chemistry
  • Reverse Transcriptase Inhibitors / pharmacology*
  • Reverse Transcriptase Inhibitors / therapeutic use
  • Virus Replication / drug effects

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Cyclopropanes
  • Oxazines
  • Reverse Transcriptase Inhibitors
  • Nevirapine
  • efavirenz